Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
15 2월 2025 - 3:42AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G Amendment No. 1 dated February 14, 2025 relating to the Common Stock, par value $0.001 per share, of Champions Oncology,
Inc. shall be filed on behalf of the undersigned.
|
TOCQUEVILLE ASSET MANAGEMENT L.P.
By: /s/ Kelsey Graham |
|
Name: Kelsey Graham |
|
Title: Chief Compliance Officer |
|
TAUBENPOST CAPITAL L.P.
By Taubenpost Capital LLC, its General Partner
By: /s/ Donald Wang |
|
Name: Donald Wang |
|
Title: Managing Member |
|
TAUBENPOST CAPITAL LLC
By: /s/ Donald Wang |
|
Name: Donald Wang |
|
Title: Managing Member |
|
DONALD WANG
By: /s/ Donald Wang |
Champions Oncology (NASDAQ:CSBR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Champions Oncology (NASDAQ:CSBR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025